Search AI Products and News

Recently, a research team from Stanford University conducted an interesting experiment exploring the role of artificial intelligence (AI) in medical diagnosis. They found that when AI transforms from a simple tool into a doctor's partner, the doctors' diagnostic accuracy improves by 10%. The study involved 70 licensed U.S. doctors, aiming to compare the effectiveness of AI with traditional diagnostic methods. Image source note: The image is generated by AI, and the image authorization service provider is Midjourney. In the experiment, doctors and AI jointly analyzed cases, with AI generating...

Alibaba's AI model, DAMO PANDA, has recently received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). This achievement marks a significant breakthrough in early pancreatic cancer screening, offering new possibilities for early diagnosis. DAMO PANDA, developed by Alibaba's DAMO Academy, is an AI model focused on pancreatic cancer screening. Its primary function is to analyze plain CT images and accurately identify subtle lesions that are difficult for the human eye to detect.

Alibaba's AI model, DAMO PANDA, has been officially designated a breakthrough medical device by the U.S. Food and Drug Administration (FDA). This certification marks a significant breakthrough for Alibaba in the field of AI-powered healthcare and represents the first time a leading Chinese tech company has received this prestigious recognition. DAMO PANDA, developed by Alibaba's DAMO Academy, is an AI model designed for pancreatic cancer screening. It aims to accurately identify subtle lesions in CT images, aiding in early detection of the disease.

In the continuous advancement of medical technology, United Imaging officially launched its latest Yuanzhi medical large model on April 9th. The launch of this large model not only brings new opportunities to the medical industry but also provides doctors and patients with more intelligent services. United Imaging's Yuanzhi large model integrates tens of millions of medical imaging data and hundreds of thousands of precisely annotated data, aiming to improve the efficiency and accuracy of image diagnosis. The Yuanzhi medical large model supports more than 10 imaging modalities and can handle 300 types of image processing tasks. This means it can...

A medical team at Ningbo University Affiliated People's Hospital recently used artificial intelligence to successfully detect early-stage pancreatic cancer in a seemingly routine case. 65-year-old Mr. Qiu visited the hospital due to dizziness for three consecutive days. While routine examinations revealed no abnormalities, the AI system, through in-depth analysis of his imaging data, issued a timely alert indicating a potential risk of pancreatic cancer. This case utilized a "Plain CT Scan + AI" approach, a cutting-edge technology that...

The University of Science and Technology of China (USTC) recently announced a significant breakthrough. Professor Sun Cheng's research group and collaborators have successfully developed the "TIMES" scoring system for predicting liver cancer recurrence, and have translated it into a publicly available, free AI diagnostic tool. The findings were published in the international academic journal Nature on March 13th, Beijing time. Liver cancer, the third leading cause of cancer-related deaths globally, has a recurrence rate of up to 70% after surgical resection. Accurate prediction of liver cancer recurrence has long been a medical challenge. The spatial distribution of immune cells in the tumor microenvironment significantly impacts patient prognosis, but previously...

Fudan University Affiliated Zhongshan Hospital and the Shanghai Institute for Advanced Study of Science jointly released CardioMind, China's first cardiovascular AI model. This innovative technology marks a new era of intelligent cardiovascular diagnosis and treatment. Referred to as an "AI cardiologist," the model aims to mimic the thinking patterns of top experts to improve efficiency in cardiovascular disease diagnosis and treatment. Academician Ge Junbo, director of cardiology, noted at the launch that CardioMind is more than just inputting data into AI.

Ping An Healthcare and Technology Company Limited has officially launched its AI-powered doctor assistant service, "Ping An Xin Yi." This service will be fully available on the Ping An Good Doctor app, providing users with around-the-clock health consultations. The digital assistant leverages advanced digital human technology and big medical data, combined with natural language processing and machine learning, to efficiently simulate the professional knowledge and experience of a real doctor. Image note: Image generated by AI, image authorization service provider Midjourney

In today’s digital age, the application of artificial intelligence has expanded across various fields. Recent studies show that AI-generated social media influencers can effectively disseminate cancer prevention information at a low cost, becoming a new option for public health communication. Cancer has been one of the leading causes of death worldwide. Despite advances in treatment methods, prevention remains the most effective way to reduce the cancer burden. According to statistics, over two-thirds of early cancer deaths in 2020 were preventable. However, most existing digital resources are largely unknown to the target audience, especially among younger individuals.

The research team from The Chinese University of Hong Kong (Shenzhen) and Shenzhen Big Data Institute has recently launched a medical large language model (LLM) named HuatuoGPT-o1. This model is specifically designed for complex reasoning in the medical field, aiming to enhance the reliability of medical diagnosis and decision-making. Unlike previous LLMs that focused on mathematical reasoning, HuatuoGPT-o1 specializes in the medical domain by simulating the rigorous thought processes of doctors in real-world practice, paving new avenues for the development of medical AI.

A new study indicates that OpenAI's o1-preview artificial intelligence system may outperform human doctors in diagnosing complex medical cases. Research teams from Harvard Medical School and Stanford University conducted a comprehensive medical diagnostic assessment of o1-preview, showing significant improvements compared to earlier versions. According to the findings, o1-preview achieved a correct diagnosis rate of 78.3% across all tested cases. In a direct comparison of 70 specific cases, the system

The application of artificial intelligence in healthcare has reached a major breakthrough! A study conducted by several top institutions, including Harvard University and Stanford University, shows that OpenAI's o1-preview model demonstrates astonishing capabilities in multiple medical reasoning tasks, even surpassing human doctors. This research not only evaluated the model's performance on medical multiple-choice question benchmarks but also focused on its diagnostic and management capabilities in simulated real clinical scenarios, yielding impressive results. Researchers conducted five experiments to assess o1-